Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
Right but 6 months ago the talk was they won’t achieve what they did in mice and it had all gone wrong hence the silence. Then it’s revealed they’re getting the protocol changed to go further. Now it was a given?
How is my post on launch misleading? The max dilution from here is 10%, many companies did fail to raise funding, some did go bust, and here we are funded til 2024/25 as per the prelims a week ago…. So which point is misleading?
How is Avacta being unable to find a maximum tolerated dose being spun into a negative? So one of the deadliest forms of chemo, Doxorubicin, being very well tolerated to the point the DEs go on is somehow worse than us finding MTD at DE3 or 4? Or put simply, it’s working so well that we’ve made a deadly chemo not deadly…. And that’s bad how?
Hahahahahaha you mean like taking the SP from 14p to where it is now, taking Avacta into clinic, moving it on from Covid unlike any other company, and proving pre|CISIONS method of action works at many times the standard dose? This P1a delay is caused by AVA6k working better than expected, so we’ll they had to re write the protocol. We’re funded into 2024/25, they raised funds in the middle of a financial crisis, when many other cos couldn’t and some went bust. The focus is entirely on heights right now and absolutely not on how well Precision, inc 3996 is performing because that’s the current agenda.
They’ve not been paid in cash once. There’s a further max dilution of 10% taking us to 300m shares in issue. That’s if Avacta continue to pay in shares. So for arguments sake someone’s 10k shares are diluted by 10% max over 5 years. Or 2% a year. Are you saying that that’s enough to put people off buying when the potential SP in that timeframe could massively take off? Or is it a case that heights are funding Avacta since that’s what they’re in it for, otherwise a capital raise would have been used instead and they’d be the largest of all holders, and they’re simply taking their profit at circa 20% average? It’s baffling to call 2% per annum the kind of dilution that would worry most, and suggest that paying in shares adds to cash burn. It’s simply wrong.
It’s not going out though is it. It’s being issued as shares. So it adds…….. nothing to cash burn. Nothing. They haven’t paid a single penny back in cash so there is no excess cash burn. So what you’re talking, on top of your 30% Gaff, it’s complete crap.